IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

Brain tumors have long been treated as rogue invaders: growing, spreading, and resisting treatment on their own. But new ...

The tumor doesn’t wait — and now, neither does the diagnosis. In a breakthrough that could drastically reduce waiting time for brain tumor patients, scientists have developed a new testing method that ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 only ...

A South Korean research team has discovered for the first time in the world that a common, intractable brain tumor in young ...

Key market opportunities in brain tumor therapeutics arise from innovations in chemotherapy, targeted therapy, and ...